Assessment of The Efficacy of The Two-Year Treatment With Omalizumab, According to The Pediatric Registry of The Children with Severe Persistent Uncontrolled Asthma

Abstract

Authors

L Namazova-Baranova E Vishneva E Dobrynina A Alekseeva J Levina K Efendieva E Antonova V Smirnov I Vinyarskaya D Chemakina V Kalugina